UNSPSC 51291509: Fenmetozole

This classification denotes an antidepressant agent with the molecular formula C10H10Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C15WFN6GMO, chemically known as 1h-imidazole, 2-((3,4-dichlorophenoxy)methyl)-4,5-dihydro- but generally known as fenmetozole, which bears US NIH Compound Identifier 32049. European Medicines Agency schedules Fenmetozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07571MIG. The term FENMETOZOLE is an International Non-Proprietary Name.

UNSPSC 51291509 Fenmetozole is a Commodity code that in recent state and local procurement activity covers pharmaceutical and medical supply acquisition, specifically naloxone and drug deactivation systems procured by county health departments for community health initiatives. State and local governments buying under this code are primarily county-level health and community services agencies. Seminole County, Florida's June 2026 IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, represents current procurement activity under the code. The solicitation requires electronic bid submission through the county's e-Procurement Portal, with bids due by July 26, 2023, and mandates unit pricing for each line item, drug-free workplace certification, E-Verify compliance, workers' compensation and commercial general liability insurance, and a three-month probationary termination clause. The contract carries a two-year initial term with a one-year renewal option and is potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act.

Recent activity under this code centers in Florida, specifically Southeast Florida health systems. The Seminole County procurement is the primary recent solicitation on record under this Commodity code, indicating that fenmetozole and related pharmaceutical supply acquisitions see limited recent state and local competitive bidding activity. Geographic concentration appears narrow, with current visibility limited to Florida county-level health department procurement. Vendors responding to opportunities under this code should confirm authorization to work in the United States, maintain required insurance coverages, and budget shipping and delivery costs within their pricing proposals.